Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
Published in:
Introduction Read chapter Read first chapter

2018 | OriginalPaper | Chapter

16. Blood Interfacing Applications

Authors : Vasif Hasirci, Nesrin Hasirci

Published in: Fundamentals of Biomaterials

Publisher: Springer New York

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Blood is a type of connective tissue and is the most difficult one to bring an implant in contact with because in addition to being biocompatible, a material has to be hemocompatible to serve as a successful implant. Hemocompatibility is defined as the property of a material not to elicit thrombosis and blood coagulation, loss or damage to platelets and other blood elements, or in short, a biomaterial’s property should not to initiate any adverse effects on blood constituents or functions. A broad series of tests are conducted in situ, in vitro, and in vivo before a material is tested on humans for its hemocompatibility. The main types of adverse effects are thrombosis (blood clotting), damage to blood cells (e.g., hemolysis of erythrocytes), adherence and decrease of blood elements such as platelets, and immune responses initiated through the various complement activation pathways.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now
previous chapter Biomaterials and Devices in Hard Tissue Augmentation
next chapter Controlled Release Systems
Literature
1.
Ratcliffe A (2000) Tissue engineering of vascular grafts. Matrix Biol 19(4):353–357CrossRef
2.
Zhang J (2016) The application and development of artificial blood vessels. 4th International Conference on Mechanical Materials and Manufacturing Engineering (MMME 2016)
3.
Ravi S, Chaikof EL (2010) Biomaterials for vascular tissue engineering. Regen Med 5(1):107CrossRef
4.
Rathore A, Cleary M, Naito Y, Rocco K, Breuer C (2012) Development of tissue engineered vascular grafts and application of nanomedicine. Nanomed Nanobiotechnol 4(3):257–272CrossRef
5.
Zilla P, Bezuidenhout D, Human P (2007) Prosthetic vascular grafts: wrong models, wrong questions and no healing. Biomaterials 28:5009–5027CrossRef
6.
Contreras MA, Quist WC, Logerfo FW (2000) Effect of porosity on small-diameter vascular graft healing. Microsurgery 20(1):15–21CrossRef
7.
Isaka M et al (2006) Experimental study on stability of a high porosity expanded polytetrafluoroethylene graft in dogs. Ann Thorac Cardiovasc Surg 12:37–41
8.
Greisler HP et al (1987) Biomaterial pretreatment with ECGF to augment endothelial cell proliferation. J Vasc Surg 5(2):393–399CrossRef
9.
Greisler HP, Cziperle DJ, Kim DU et al (1992) Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment. Surgery 112(2):244–254
10.
Ahmed F et al (2014) Engineering interaction between bone marrow derived endothelial cells and electrospun surfaces for artificial vascular graft applications. Biomacromolecules 15:1276–1287CrossRef
11.
Sarkar S, Sales KM, Hamilton G, Seifalian AM (2007) Addressing thrombogenicity. J Biomed Mater Res B Appl Biomater 82(1):100–108CrossRef
12.
de Valence S et al (2013) Plasma treatment for improving cell biocompatibility of a biodegradable polymer scaffold for vascular graft applications. Eur J Pharm Biopharm 85:78–86CrossRef
13.
Ren X, Feng Y, Guo J, Wang H, Li Q, Yang J, Hao X, Lv J, Ma N, Li W (2015) Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications. Chem Soc Rev 44:5680CrossRef
14.
Tanzi MC, Mantovani D, Petrini P, Guidoin R, Laroche G (1997) Chemical stability of polyether urethanes versus polycarbonate urethanes. J Biomedical Mater Res 36:550–559CrossRef
15.
He W, Yong T, Ma ZW, Inai R, Teo WE, Ramakrishna S (2006) Biodegradable polymer nanofiber mesh to maintain functions of endothelial cells. Tissue Eng 12(9):2457–2466CrossRef
16.
Xu C, Inai R, Kotaki M, Ramakrishna S (2004) Electrospun nanofiber fabrication as synthetic extracellular matrix and its potential for vascular tissue engineering. Tissue Eng 10(7–8):1160–1168CrossRef
17.
Stankus JJ, Guan J, Fujimoto K, Wagner WR (2006) Microintegrating smooth muscle cells into a biodegradable, elastomeric fiber matrix. Biomaterials 27(5):735–744CrossRef
18.
Shin'oka T, Imai Y, Ikada Y (2001) Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 344(7):532–533CrossRef
19.
This file is licensed under the Creative Commons Attribution-Share Alike 3.0 Unported license
20.
Hinton RB, Yutzey KE (2011) Heart valve structure and function in development and disease. Annu Rev Physiol 73:29–46CrossRef
21.
Gurvitch R, Cheung A, Ye J, Wood DA, Willson AB, Toggweiler S et al (2011) Transcatheter valve-in-valve implantation for failed surgical bioprosthetic valves. J Am Coll Cardiol 58(21):2196–2209CrossRef
22.
Mohammadi H, Mequanint K (2011) Prosthetic aortic heart valves: modeling and design. Med Eng Phys 33(2):131–147CrossRef
23.
Hilbert SL, Ferrans VJ, Tomita Y, Eidbo EE, Jones M (1987) Evaluation of explanted polyurethane trileaflet cardiac valve prostheses. J Thorac Cardiovasc Surg 94(3):419–429
24.
Kiraly R, Yozu R, Hillegass D, Harasaki H, Murabayashi S, Snow J et al (1982) Hexsyn trileaflet valve: application to temporary blood pumps. Artif Organs 6(2):190–197CrossRef
25.
Nistal F, Garcia-Martinez V, Arbe E, Fernandez D, Artinano E, Mazorra F et al (1990) In vivo experimental assessment of polytetrafluoroethylene trileaflet heart valve prosthesis. J Thorac Cardiovasc Surg 99(6):1074–1081
26.
Dabagh M, Abdekhodaie MJ, Khorasani MT (2005) Effects of polydimethylsiloxane grafting on the calcification, physical properties, and biocompatibility of polyurethane in a heart valve. J Appl Polym Sci 98:758–766CrossRef
27.
INNOVIA LLC. Patent filed 2004, Registration Number 3446421
28.
Bezuidenhout D, Williams DF, Zilla P (2015) Polymeric heart valves for surgical implantation, catheter-based technologies and heart assist devices. Biomaterials 36:6–25CrossRef
29.
Gallocher SL, Aguirre AF, Kasyanov V, Pinchuk L, Schoephoerster RT (2006) Novel polymer for potential use in a trileaflet heart valve. J Biomed Mater Res B Appl Biomater 79(2):325–334CrossRef
30.
Kannan RY, Salacinski HJ, Ghanavi JE, Narula A, Odlyha M, Peirovi H et al (2007) Silsesquioxane nanocomposites as tissue implants. Plast Reconstr Surg 119(6):1653–1662CrossRef
31.
Punshon G, Sales KM, Vara DS, Hamilton G, Seifalian AM (2008) Assessment of the potential of progenitor stem cells extracted from human peripheral blood for seeding a novel vascular graft material. Cell Prolif 41(2):321–335CrossRef
32.
van Neer PLMJ, Bouakaz A, Vlaanderen E, de Hart J, Van de Vosse FN, van der Steen AFW, de Jong N (2006) Detecting broken struts of a Björk-Shiley heart valve using ultrasound: a feasibility study. Ultrasound Med Biol 32(4):503–512CrossRef
33.
Shiltman MI (2003) New concepts in polymer science
34.
Cooley DA (2001) The total artificial heart as a bridge to cardiac transplantation. Tex Heart Inst J 28(3):200–202
35.
Gray NA, Selzman CH (2006) Current status of the total artificial heart. Am Heart J 152(1):4–10CrossRef
36.
37.
Whittaker DR, Fillinger MF (2006) The engineering of endovascular stent technology: a review. Vasc Endovasc Surg 40(2):85–94CrossRef
38.
Heublein B, Rohde R, Kaese V, Niemeyer M, Hartung W, Haverich A (2003) Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart 89(6):651–656CrossRef
39.
Cloft HJ, Kallmes DF, Lin HB, Li ST, Marx WF, Hudson SB et al (2000) Bovine type I collagen as an endovascular stent-graft material: biocompatibility study in rabbits. Radiology 214(2):557–562CrossRef
40.
Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK et al (2003) A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 348(16):1537–1545CrossRef
41.
Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T et al (2005) Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16(3):331–338CrossRef
42.
Claessen BE, Henriques JP, Dangas GD (2010) Clinical studies with sirolimus, zotarolimus, everolimus, and biolimus A9 drug-eluting stent systems. Curr Pharm Des 16(36):4012–4024CrossRef
43.
Kim K-H et al (2012) Comparison of drug-eluting versus bare-metal stent implantation in ST-elevation myocardial infarction patients with renal insufficiency: results from the national registry in Korea. Int J Cardiol 154(1):71–77CrossRef
44.
Bangalore S, Gupta N, Guoa Y, Feit F (2014) Trend in the use of drug eluting stents in the United States: insight from over 8.1 million coronary interventions. Int J Cardiol 175:108–119CrossRef
45.
Federspiel WJ, Henchir KA (2004) Lung, artificial: basic principles and current applications. In: Encyclopedia of biomaterials and biomedical engineering. University of Pittsburgh, Pittsburgh, PA, pp 910–921
46.
AAMI, S. A. R. P (1996) Association for the Advancement of medical instrumentation. Volume 2.1 biomedical equipment, part 1, equipment therapy and surgery cardiovascular implants and artificial organs: blood gas exchangers. AAMI 7199:633–648
47.
Weibel ER (1984) The pathway for oxygen: structure and function in the mammalian respiratory system. Harvard University Press, Cambridge, MA
48.
49.
Gabelman A, Hwang ST (1999) Hollow fiber membrane contactors. J Membr Sci 159(1):61–106CrossRef
50.
This is a file from the Wikimedia Commons. This file is licensed under the Creative Commons Attribution 3.0 Unported license
51.
Yang Z, Matsumoto S, Maeda R (2002) A prototype of ultrasonic micro-degassing device for portable dialysis system. Sensors Actuators 95:274–280CrossRef
Metadata
Title
Blood Interfacing Applications
Authors
Vasif Hasirci
Nesrin Hasirci
Copyright Year
2018
Publisher
Springer New York
Book
Fundamentals of Biomaterials

Print ISBN: 978-1-4939-8854-9

Electronic ISBN: 978-1-4939-8856-3

Copyright Year: 2018

DOI
https://doi.org/10.1007/978-1-4939-8856-3_16

Premium Partners

    Image Credits